Pharma Industry News

Oncology: And then there were five

Written by David Miller

Print section

UK Only Article: 
standard article

Issue: 

Entangled

Fly Title: 

Oncology

Location: 

CHICAGO

Main image: 

20150606_STD001_0.jpg

THERE are, broadly speaking, four ways to fight cancer. You can cut a tumour out, with surgery. Or you can try one of three different ways of killing it. Radiotherapy targets tumours with radiation. Chemotherapy uses chemicals that poison all rapidly dividing cells, cancerous ones included. “Targeted therapies”, as their name suggests, recognise particular features specific to cancer cells.
Singly and in combination, these four types of treatment have contributed to a steady increase in the survival rates for most kinds of cancer. Now they may be joined by a fifth. At this year’s meeting of the American Society of Clinical Oncology (ASCO), in Chicago, the assembled researchers heard about the latest progress in “immuno-oncology”.

Modern medicine provides every reason to think that the immune system—which, after all, is there to keep the rest of the body …Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]